|Day Low/High||37.16 / 37.59|
|52 Wk Low/High||33.88 / 64.50|
Jim Cramer says healthcare companies will be in the spotlight this week and investors should take a long term view of the sector if the stocks selloff.
With stocks down over 10% since the start of the year, it is crucial to stay disciplined.
U.S. stock futures, global markets fall across the board due to oil drifting below $30 per barrel.
U.S. stocks made a surprise bounce higher shortly after sinking into the red.
Stocks struggled all week to escape the gloom and doom.
Consumers are taking that extra cash out of their pockets.
TheStreet’s Action Alerts PLUS Portfolio Manager Jim Cramer isn’t a fan of the volatility index, or VIX, amid the global markets sell off.
U.S. stocks took a dive at the open on Thursday in response to further instability in China.
In 'What to Watch on Wall Street' for Thursday January 7, earnings season is picking up again and investors will hear from a number of companies.
We will consider opportunistically adding to positions, keeping an eye to our cost basis, in this market.
In 'What to Watch on Wall Street' for the week of January 4, investors will get a mix of both earnings and economic reports to start off the new year.
If WBA breaks down from here, the next support area looks to be around $70 or so.
For Thursday December 17, TheStreet awaits quarterly results from General Mills (GIS), Rite Aid (RAD) and Red Hat (RHT).
Stocks rallied Wednesday as the veil of uncertainty over rates was lifted.
It indicates future increases will be modest and gradual and will take into account domestic and international developments.
Following the rally in some of the most talked-about short positions this year, several calls are about to be covered.
A bunch of factors converged over the last 24 hours to give a lift to the market.
We view the news as a positive, especially for our financial and retail/consumer names.
Homebuilders and regional banks are just 2 of the areas a Fed move would affect.
Longs should protect their positions and take appropriate action on a close below $80.
TheStreet's Jim Cramer says based on valuation, investors should buy Allergan (AGN) over Pfizer (PFE) because the two are moving closer to an acquisition.
TheStreet's Jim Cramer is keeping an eye on CVS (CVS) and Chevron (CVX) on Friday as both companies release their latest quarterly results before the opening bell.
Jim Cramer, The Street's Action Alerts PLUS Portfolio Manager and host of CNBC's 'Mad Money,' said Allergan (AGN) is a stock to hold onto.
Writing about the market on a flight to Colorado isn't nearly as nuts as the action is today.
Drugs store Walgreens Boots Alliance (WBA) has announced that it will buy smaller rival Rite Aid (RAD) for $17.2 billion.
For Wednesday October 28, TheStreet awaits quarterly results from Walgreens Boots Alliance (WBA), Mondelez (MDLZ), Fiat Chrysler (FCAU), Amgen (AMGN), PayPal (PYPL), Buffalo Wild Wings (BWLD) and more.